Recent Updates
Recently added Catalysts
KPTI Positive Sentiment

Karyopharm to Report Second Quarter 2024 Financial Results on August 6, 2024

Wednesday, July 31, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Karyopharm Therapeutics Inc. has announced its plans to report its financial results for the second quarter of 2024 on August 6, 2024. The announcement includes a scheduled conference call at 8:00 a.m. ET where the management team will discuss the financial outcomes and other updates. Investors can participate by calling in or accessing a live audio webcast, which will be available on the company's website.
Price reaction · baseline $15.9 (2024-07-30 close) · hit after-hours · 1 other KPTI headline(s) in the window, move may be shared
day 0 close
-6.7%
day 1
-12.9%
day 3 · peak
-17.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Karyopharm is set to report its second quarter 2024 financial results.
  • The company is facilitating a conference call to discuss results and updates.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+105%
120-day peak, hindsight
Typical move
15.1%
average across 5 past catalysts
Cash runway
~8 mo
Medium dilution risk
Lead asset
Selinexor
Phase 2 · Acute Myeloid Leukemia (AML)

Full Press Release Details

-- Conference Call Scheduled for Tuesday, August 6, 2024, at 8:00 a.m. ET --
NEWTON, Mass., July 31, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report second quarter 2024 financial results on Tuesday, August 6, 2024. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m. ET on Tuesday, August 6, 2024, to discuss the financial results and other company updates.
To access the conference call, please dial (800) 836-8184 (local) or (646) 357-8785 (international) at least 10 minutes prior to the start time and ask to be joined into the Karyopharm Therapeutics call. A live audio webcast of the call, along with accompanying slides, will be available under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations. An archived webcast will be available on the Company's website approximately two hours after the event.
About Karyopharm Therapeutics
XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc. Any other trademarks referred to in this release are the property of their respective owners.

Frequently Asked Questions

When will Karyopharm report its Q2 2024 financial results?

Karyopharm will report its Q2 2024 financial results on August 6, 2024.

What time is Karyopharm's conference call scheduled?

The conference call is set for 8:00 a.m. ET on August 6, 2024.

How can I access the Karyopharm conference call?

Dial (800) 836-8184 locally or (646) 357-8785 internationally 10 minutes before the call.

Will there be a webcast of the conference call?

Yes, a live audio webcast will be available under 'Events & Presentations' on their website.

Where can I find the archived webcast after the call?

The archived webcast will be available on Karyopharm's website about two hours post-event.

ShareAdd on Google
Tags: KPTI Viatris Investor Conferences Healthcare Karyopharm financial results conference call cancer therapies
Last updated: Jul 31, 2024

Biotech snapshot

Cash runway
$65M liquidity · $8M/mo burn
~8 mo
Medium dilution risk
Lead asset
SelinexorPhase 2
Acute Myeloid Leukemia (AML) →

Catalyst track record

+105%
best trade around KPTI's most recent catalyst

Peak hindsight return over a 120-day window, across 5 tracked FDA/PDUFA catalysts for KPTI.

See every catalyst's timing & PoA →